ARTICLE | Company News
Alpha 1 Biomedicals, SciClone deal
October 10, 1994 7:00 AM UTC
The companies completed a previously announced licensing agreement that granted SCLN (San Mateo) additional rights to develop and commercialize thymosin alpha 1 to treat hepatitis B. SCLN now holds wo...